We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HHS SHIFT ALLOWS QUICK REVIEW OF COMBINATION AIDS DRUGS
HHS SHIFT ALLOWS QUICK REVIEW OF COMBINATION AIDS DRUGS
May 21, 2004
Brand and generic drugmakers could find it a lot easier to submit applications for fixed-dose combination (FDC) products to be used to treat HIV in poor countries, after U.S. health officials announced they were shifting policy in a move that could usher in new brand FDC drugs and allow generic firms to sell FDC products that are still under patent.